Our core team is composed of international leaders in drug development, Cardiovascular & Metabolic research, clinical translation, and development of new targets and indications. They have expertise in designing POC according to biological mechanism and targets in developing projects, while collecting efficacy data as early as possible to help timely decision-making. 

· Operational experience in conducting FIH and POC across North America, Europe and Asia-Pacific region.

· Deep understanding of regulatory requirements in China, Western Europe and North America.